U.S. FDA asks J&J to discard 60 million vaccine doses made at Baltimore plant -NYT
Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated.